Usefulness of the Medissimo Nurse Application for Supporting Medication Compliance in Elderly People With Chronic Polypathologies
1 other identifier
observational
160
0 countries
N/A
Brief Summary
In this study, the investigators are interested in the Medissimo nurse application, which is a medication monitoring application for the elderly dedicated to self-employed nurses. The aim is to estimate the consistency of the measure of medication compliance assessed by this application with reference measures, as well as the user experience of healthcare professionals with this application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2023
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2023
CompletedFirst Posted
Study publicly available on registry
August 29, 2023
CompletedStudy Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedAugust 29, 2023
August 1, 2023
6 months
August 9, 2023
August 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Socio-demographic data (for all participants) Medical data
Descriptive statistics on data (mean, standard deviation, median)
about 3 months
Secondary Outcomes (5)
Patient analyses : Pill counting
about 3 months
Patient analyses : Recording of omissions in the monthly compliance report of patients taking part in the study
about 3 months
Patient analyses : Morisky questionnaire
about 3 months
Analysis of professionals : User experience analysis
about 3 months
Analysis of professionals : Analysis of healthcare professionals' assessments
about 3 months
Study Arms (2)
100 Patients
* Socio-demographic data (age, gender, lifestyle, medication management aids) * Medical data (number and type of medications) * Variables for calculating assessment criteria: \< Pill count: this is a simple way of estimating compliance with medication. The pharmacist will calculate the pill count. The remaining pills (not taken by the patient) are brought to the pharmacist, who then calculates them. The pill count is not used as part of routine care for Medipac beneficiaries. \< The Morisky adherence questionnaire is an 8-item hetero-questionnaire used to measure adherence to treatment. It will be carried out by the home care nurse as part of routine care. The scores can be interpreted as follows: ≥ 8: good adherence; 6 to 7: average adherence; \< 6: poor adherence.
Healthcare professionals (20 doctors, 20 pharmacists and 20 nurses)
* Socio-demographic data (age, gender, profession) * Evaluation of the user experience using the SUS (Sytem usability scale) questionnaire. This is an easy-to-use Likert-type scale consisting of 10 questions. The aim is to assess the point of view of the person using the Medissimo nurse application, after having had the opportunity to use it. The questions offer quick answers, ranging from "strongly disagree" to "strongly agree". * Assessment of the monthly reports produced by the application for nurses, GPs and pharmacists. Using a Likert-type questionnaire, they will be asked to describe their satisfaction, and the beneficial or negative aspects of this application in relation to patient monitoring. The questionnaire consists of 12 questions, 10 of which offer the following 5 responses: "Strongly agree"; "Agree"; "Neither disagree nor agree"; "Disagree"; "Strongly disagree", and 2 short-answer, open-ended questions.
Interventions
For patients and professionals: retrieval of socio-demographic data For patients : * Pill counting * Morisky questionnaire
For patients and professionals: retrieval of socio-demographic data For healthcare professionals : * Evaluation of user experience * Evaluation of the report produced by the application
Eligibility Criteria
Medissimo will contact 100 pharmacies that use the Medipac® system to ask them to take part in the study. The pharmacists to whom the study will be proposed will be selected from users in the Paris region for reasons of geographical proximity. Patients will be selected from among Medipac® pillbox users dispensed by pharmacists who agree to take part in the study. All patients of pharmacists who accept and receive home visits by private nurses (beneficiaries of the Medissimo nurse application) will be considered eligible. We expect to include 5 patients per pharmacist (i.e. a total of 100 patients). As far as the patients are concerned, their nurse will have to be informed of the study, will give them the information letter and will have to ensure that they do not object to taking part. The professionals (nurses, GPs and pharmacists) will be selected from Medissimo and chosen at random. The study investigator will contact them to offer to participate and to seek their consent.
You may qualify if:
- People aged over 65 receiving more than 5 chronic medications
- Person agreeing to take part in the study
- Person living at home receiving home nursing care as part of routine care
- Person whose carer is already a user of the application under study
- Home nurses who have been using the Medissimo nurse application for at least 1 month and who agree to take part in the study or
- Private practitioners who agree to take part in the study or
- Pharmacists who have been using the Medissimo nurse service for at least 1 month and who agree to take part in the study.
You may not qualify if:
- Refusal to take part in the study
- Person in palliative care
- Person under protection, guardianship or curatorship
- \- Refusal to take part in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RIVAGESlead
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joël Belmin, Professor
Association Rivages
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2023
First Posted
August 29, 2023
Study Start
September 1, 2023
Primary Completion
March 1, 2024
Study Completion
April 1, 2024
Last Updated
August 29, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share